Market Leads & Opportunities
Pipeline Framework: NHS National Proprietary Pharmaceuticals – Eculizumab biosimilar
A pipeline has been launched for NHS National Proprietary Pharmaceuticals – Eculizumab biosimilar.The contract start Date is 1 December 2023. Approach to market date is 1 May 2023.CM/PHR/22/5693 NHS National Proprietary Pharmaceuticals – Eculizumab biosimilarThis is a potential opportunity from the government, and the pipeline gives advance notice of an opportunity that might be offered by the public sector in the future – allowing potential suppliers to plan accordingly. When a public sector organisation publishes a pipeline notice, it does not necessarily mean that an opportunity will be offered in the future.For more information contact: NHS England, Rutland House, Runcorn WA7 2ES. Email: katie.noonan@nhs.net (Branded Team)
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
- In association with::
